From the September 2018 issue of HealthCare Business News magazine
By Michael Friebe
For about 45 years, MR has combined strong magnetic fields and mathematical models to provide excellent soft tissue contrast and, these days, even molecular information.
But these systems have retained certain undesirable traits: they are massively heavy, require special environments, take a long time to perform scans and are hampered by high investment and running costs.
There are at least 25,000 units very unevenly installed in the world (depending on the country of installation between 1 MR for every 10,000 to 1 MR for every 10 million population) producing on the order of 100 million patient exams per year globally.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
Research over the last few years has focused on increasing resolution, signal to noise ratio, and speeding up the examination time. Experts sought additional applications, faster contrast scans of the lungs, simplification of cardiac imaging workflows, and to address specific needs of changing demographics (aging population and multimorbid patients).
Economic pressure, the need for personalized treatment, and the increased imaging requirements of precision medicine are putting additional pressure on the future performance and features of MR systems. A lot of these issues are directly related to the MR systems magnet/magnetic field and therefore, one area of research in recent years was to implement higher and higher field strength magnets. This, however, comes with even stricter siting requirements and higher costs, as the entire environment has to be adapted to the constraints of the MR.
These days, innovation is being driven by new acquisition and dedicated imaging software (e.g., compressed sensing for reduced overall scan time, while maintaining resolution and image quality), and post-processing programs for better, faster cancer diagnosis using automation (which also has the benefit of increased reproducibility and high quality), artificial intelligence, deep learning, and big data.
Other developments have focused on adding MR to other modalities – combinations with linear accelerators were one of the RSNA 2017 highlights.
It is foreseeable that this will lead to a very streamlined and possibly almost completely automated acquisition and interpretation of the acquired MR images in the next 5-10 years. But are we ready yet to accept a diagnostic report that comes from a program rather than from a human? While there is scientific evidence that narrow artificial intelligence-based programs are already superior to the human created reports there are still many philosophical, moral, and ethical questions. For example the dual-use (good and evil) nature of research and development needs to be discussed and dealt with if we completely rely on programs in the future.